326 related articles for article (PubMed ID: 15913971)
1. [Streptococcus pyogenes an emerging pathogen].
Cohen R; Aujard Y; Bidet P; Bourrillon A; Bingen E; Foucaud P; François M; Garnier JM; Gendrel D; Guillot M; Hau I; Olivier C; Quinet B; Raymond J
Arch Pediatr; 2005 Jul; 12(7):1065-7. PubMed ID: 15913971
[No Abstract] [Full Text] [Related]
2. [Resistance to penicillin and erythromycin of Streptococcus pneumoniae and Streptococcus pyogenes isolated from community-acquired respiratory infections in Spain between 1986-1999 and its relationship with the use of beta-lactams and macrolides].
Granizo Martínez JJ
Rev Esp Quimioter; 2005 Mar; 18(1):83-5. PubMed ID: 15915241
[No Abstract] [Full Text] [Related]
3. [Resistance to macrolides in Streptococcus pyogenes].
Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
[No Abstract] [Full Text] [Related]
4. [Susceptibility of Streptococcus pyogenes to penicillin, macrolides and clindamycin in Cádiz].
Marín P; Márquez A; García-Martos P; García-Tapia A; Tapia J
Rev Esp Quimioter; 2000 Sep; 13(3):318-9. PubMed ID: 11086284
[No Abstract] [Full Text] [Related]
5. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
[TBL] [Abstract][Full Text] [Related]
6. Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.
Mihaila-Amrouche L; Bouvet A; Loubinoux J
J Clin Microbiol; 2004 Aug; 42(8):3844-6. PubMed ID: 15297545
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
Colakoglu S; Alacam R; Hascelik G
Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
[TBL] [Abstract][Full Text] [Related]
8. [Streptococcus pyogenes or group A streptococcal infections in child: French national reference center data].
Bidet P; Plainvert C; Doit C; Mariani-Kurkdjian P; Bonacorsi S; Lepoutre A; Bouvet A; Poyart C; Bingen E
Arch Pediatr; 2010 Feb; 17(2):201-8. PubMed ID: 19926269
[TBL] [Abstract][Full Text] [Related]
9. Streptococcal pharyngitis: alternative treatments.
Kieserman SP; Williams J; Linstrom C
Ear Nose Throat J; 1995 Nov; 74(11):777-80. PubMed ID: 8536567
[No Abstract] [Full Text] [Related]
10. [Update on antibiotic sensitive Streptococcus pyogenes in a pediatric population].
Gené A; González-Cuevas A; Muñoz C; Luaces C; Latorre C
Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):144-5. PubMed ID: 10905020
[No Abstract] [Full Text] [Related]
11. Clinical and bacteriological implications of macrolide resistance in group A streptococcal pharyngitis.
Martin-Herrero JE; Garcia-Rey C; Dal-Ré R; Aguilar L
J Antimicrob Chemother; 2003 Oct; 52(4):735-6. PubMed ID: 12951332
[No Abstract] [Full Text] [Related]
12. [Macrolides in the treatment of streptococcal pharyngitis: not all effective].
Alós JI
Med Clin (Barc); 1999 Jan; 112(1):18-9. PubMed ID: 10027181
[No Abstract] [Full Text] [Related]
13. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance in streptococcal pharyngitis.
Lavergne V; Thibault L; Garceau R
CMAJ; 2007 Jul; 177(2):177. PubMed ID: 17638961
[No Abstract] [Full Text] [Related]
15. [Toxic shock-like syndrome caused by streptococci--treated with clindamycin].
Nørgaard M
Ugeskr Laeger; 1997 Apr; 159(16):2396-7. PubMed ID: 9163118
[TBL] [Abstract][Full Text] [Related]
16. Group A streptococcus and its antibiotic resistance.
Passàli D; Lauriello M; Passàli GC; Passàli FM; Bellussi L
Acta Otorhinolaryngol Ital; 2007 Feb; 27(1):27-32. PubMed ID: 17601208
[TBL] [Abstract][Full Text] [Related]
17. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
Sawai J; Hasegawa T; Kamimura T; Okamoto A; Ohmori D; Nosaka N; Yamada K; Torii K; Ohta M
Antimicrob Agents Chemother; 2007 Feb; 51(2):461-7. PubMed ID: 17101685
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pyogenes and beta-lactam antibiotics.
Del Giudice P
Pediatr Dermatol; 2008; 25(5):577. PubMed ID: 18950409
[No Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program.
Gracia M; Díaz C; Coronel P; Gimeno M; García-Rodas R; Rodríguez-Cerrato V; del Prado G; Huelves L; Ruiz V; Naves PF; Ponte MC; Granizo JJ; Soriano F
Diagn Microbiol Infect Dis; 2009 May; 64(1):52-6. PubMed ID: 19232860
[TBL] [Abstract][Full Text] [Related]
20. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
